Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in... see more

TSXV:BTI.H - Post Discussion

biOasis Technologies Ord Shs > Here's the bottom line.
View:
Post by JDavenport on Dec 13, 2022 7:49pm

Here's the bottom line.

Bioasis, with a market cap tonight of CDN $11.5 million, is being bought by a company that goes to bed tonight with a market cap of only about CDN $6 million, and Bioasis shareholders end up with less than 10% of the resulting company.

Together, current Midatech and Bioasis shareholders will end up with less than 50% of the resulting company, meaning that control of the resulting company goes, it appears, to investors brought to the table by Ladenburg Thalmann.

The resulting company can do anything it wants without a single vote from current Midatech and Bioasis shareholders, including selling the company to private concerns, or selling xB3 to private concerns and running the Midatech/Bioasis combination on Cresence EGF stuff.

It looks to me like the current Midatech shareholders are just about as exposed as Bioasis shareholders are.

jd
Comment by prophetoffactz on Dec 13, 2022 8:44pm
What's the market cap of the new company? How much cash? Does it have the financial wherewithal, scientific teams, and clinical trial infrastructure to advance xB3 on its own with the other clinical stage assets and to enter more substantial strategic alliances, etc. How can the various technology be used together? How undervalued was the other company itself helping to offset some of the ...more  
Comment by JDavenport on Dec 13, 2022 9:06pm
Does it make any difference, pof? Rathjen and Ladenburg Thalmann may have just killed off both companies. I don't care what you post. It's what is happening and will happen that counts. Both Midatech and Bioasis shareholders will lose control of their companies with this deal. If xB3 works then I predict it will end up in private hands. And no, it doesn't look like the new entity is ...more  
Comment by unclepieman on Dec 13, 2022 9:34pm
What a bunch of nonsense! all you have ever said until recent is how amazing things are and how we are all wrong and you and BTO execs are leading to amazing shareholder value!!! stop trying to rewrite history with your lies! what a JOKE!   
Comment by unclepieman on Dec 13, 2022 9:36pm
In fact if I decide to sue BTI, you JD will be listed personally on there for misleading the shareholders!!!
Comment by JDavenport on Dec 13, 2022 9:48pm
Hah! Go ahead, uncle. I'm on the record. I posted for years that some form of this could happen, and it went right over your head. You heard only what you wanted to hear, believed only what you wanted to believe. And I think I'm almost certainly right about the potential value of xB3 and that there are deals that will be done with it. More to the point, I believe it very possible that ...more  
Comment by Finallytherock on Dec 14, 2022 7:36am
JD is mentally ill. you can't say otherwise. i guess i would be too if i put so much of my time into a company for the last 15  years only to be proven wrong over and over and over again and have nothing to show for it. This stock has truly been his life based on the time he has put into it whether it's posting here or on his silly little blog. It still cracks me up the company ...more  
Comment by prophetoffactz on Dec 13, 2022 9:41pm
"Rathjen and Ladenburg Thalmann may have just killed off both companies." With 25% of biotech companies trading below cash in recent months these two companies on life support have been given a second chance where many won't be. While there is a ways to go for many to recover and be made whole at least together these companies are viable in a very difficult biotech environment and ...more  
Comment by JDavenport on Dec 13, 2022 9:50pm
Pof says, "Ladenberg is in." Pof has a flair for the obvious. But are the shareholders out? jd
Comment by prophetoffactz on Dec 13, 2022 10:03pm
If they managed risk right and didn't overweight BTI in a portfolio context this can be an opportunity. We've been in the worst biotech market in history. Many companies are hurting and will go under. Is xB3 now in the strongest position ever to move forward. Is it a worthwhile risk/reward opportunity.  
Comment by JDavenport on Dec 13, 2022 10:26pm
Ugh! That's gobbledeegook, pof. Go read the resulting ownership details in this table. Tell us that the loss of controlling interest by the curent shareholders of both companies isn't a worrisome thing. No, xB3 is not in a position to move forward. It's a technology. It can't move itself forward. The question is, who will do it and who will benefit from it? Your ...more  
Comment by unclepieman on Dec 13, 2022 10:52pm
Lol are you done? You are exactly as you were before only now on the other side of the coin! I am concerned that you might actually need help!
Comment by JDavenport on Dec 13, 2022 11:09pm
Uncle, this may be difficult. Pay attention. Consider this statement: "If this happens, then that can happen." That's two sides of the coin. Implicit is that if this does not happen, then the other thing won't happen. And that is how I have always spoken about Bioasis, but all that you ever filtered out of it was "this is going to happen," something that I would ...more  
Comment by JDavenport on Dec 13, 2022 11:41pm
Sorry, that was EditPad Pro, not EditPro. jd
Comment by unclepieman on Dec 13, 2022 9:30pm
You are so clueless! It's called a lawsuit in the making of that happens! :)
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities